Fig. 1From: EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approachesEZH2 Expression (a) EZH2 expression evaluated through real time PCR in sample control (CTRL), Jurkat and T-ALL samples. PRC2 expression evaluated through immunoblotting (b) in T-ALL samples enrolled in the study and (c) representation of the densities of the bands corresponding to EZH2, SUZ12 and EED expressed as percentage of expression after laser scanningBack to article page